|
|
| NDC Number | Brand Name | Generic Name | Labeler | Dosage Form | DEA Schedule | Marketing Start Date |
|---|---|---|---|---|---|---|
| 0002-7772 | EBGLYSS | lebrikizumab-lbkz | Eli Lilly and Company | INJECTION, SOLUTION | 2024-09-13 | |
| 0002-7797 | EBGLYSS | lebrikizumab-lbkz | Eli Lilly and Company | INJECTION, SOLUTION | 2024-09-13 | |
| 50222-346 | Adbry | tralokinumab-ldrm | LEO Pharma Inc. | INJECTION, SOLUTION | 2022-01-02 | |
| 50222-350 | Adbry | tralokinumab-ldrm | LEO Pharma Inc. | INJECTION, SOLUTION | 2024-07-01 |
Loading full table content...